Established
Semaglutide
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Drogau incretin
Tystiolaeth dreial ar gyfer pob drug, gyda'r data ar ddiddymu y mae marchnata'n tueddu i'w gadael allan.
Established
Tirzepatide
Dual GIP / GLP-1 receptor agonist. Mounjaro, Zepbound
Established
Liraglutide
GLP-1 receptor agonist. Victoza, Saxenda
Established
Dulaglutide
GLP-1 receptor agonist. Trulicity
Promising
Oral semaglutide
GLP-1 receptor agonist, oral. Rybelsus
Popular but weak
Compounded GLP-1 preparations
Unapproved compounded preparation. Various, unbranded
Darllen cysylltiedig
Fasting Evidence
Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.
Metabolism Review
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Weight Loss Evidence
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep Evidence
Sleep, circadian rhythm and the wearables that claim to measure both.
Cafodd y dudalen hon ei thrawsgrifiad yn awtomatig o Saesneg. Mae'r dyfyniadau a'r rhifau heb newid. Darllenwch y gwreiddiol Saesneg os yw unrhyw beth yn darllen yn rhy ddieithr. Darllenwch y gwreiddiol Saesneg